EBS - Emergent Biosolutions EPS beats by $0.03 beats on revenue August, 01 2019 04:57 PM Emergent Biosolutions Inc. Emergent Biosolutions (NYSE:EBS): Q2 Non-GAAP EPS of -$0.12 beats by $0.03; GAAP EPS of -$0.18 misses by $0.03.More news on: Emergent BioSolutions Inc., Earnings news and commentary, Healthcare stocks news, Read more ...